Terumo (4543) Stock Overview
Engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for 4543 from our risk checks.
4543 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Terumo Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,492.50 |
| 52 Week High | JP¥3,182.00 |
| 52 Week Low | JP¥2,352.00 |
| Beta | 0.38 |
| 1 Month Change | -1.11% |
| 3 Month Change | 3.06% |
| 1 Year Change | -13.99% |
| 3 Year Change | 13.58% |
| 5 Year Change | 27.95% |
| Change since IPO | 1,998.95% |
Recent News & Updates
Here's Why We Think Terumo (TSE:4543) Is Well Worth Watching
Oct 08
Terumo's (TSE:4543) Upcoming Dividend Will Be Larger Than Last Year's
Sep 22Terumo's (TSE:4543) Upcoming Dividend Will Be Larger Than Last Year's
Sep 08Recent updates
Here's Why We Think Terumo (TSE:4543) Is Well Worth Watching
Oct 08Terumo's (TSE:4543) Upcoming Dividend Will Be Larger Than Last Year's
Sep 22Terumo's (TSE:4543) Upcoming Dividend Will Be Larger Than Last Year's
Sep 08Terumo (TSE:4543) Has Announced That It Will Be Increasing Its Dividend To ¥15.00
Aug 25Terumo Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Aug 10Why Investors Shouldn't Be Surprised By Terumo Corporation's (TSE:4543) P/E
Aug 07Terumo (TSE:4543) Is Increasing Its Dividend To ¥15.00
Jul 25Terumo (TSE:4543) Seems To Use Debt Rather Sparingly
Jul 24Terumo's (TSE:4543) Upcoming Dividend Will Be Larger Than Last Year's
Jul 11Here's Why We Think Terumo (TSE:4543) Is Well Worth Watching
Jul 09Terumo (TSE:4543) Has More To Do To Multiply In Value Going Forward
Jun 21We Like The Quality Of Terumo's (TSE:4543) Earnings
May 21Earnings Miss: Terumo Corporation Missed EPS By 9.8% And Analysts Are Revising Their Forecasts
May 18Terumo (TSE:4543) Has A Rock Solid Balance Sheet
Apr 17Terumo Corporation's (TSE:4543) Earnings Haven't Escaped The Attention Of Investors
Mar 18Terumo Corporation (TSE:4543) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year
Feb 16Return Trends At Terumo (TSE:4543) Aren't Appealing
Feb 10Terumo (TSE:4543) Could Easily Take On More Debt
Jan 11Calculating The Intrinsic Value Of Terumo Corporation (TSE:4543)
Dec 26Terumo Corporation (TSE:4543) Not Flying Under The Radar
Dec 11Terumo Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Nov 11
Tactical Innovation And Global Expansion Set The Stage For Impressive Growth
Terumo's innovation and new market creation focus, including entering the venous intervention market, aim to drive future sales and revenue growth.Returns At Terumo (TSE:4543) Appear To Be Weighed Down
Nov 08Shareholder Returns
| 4543 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | -0.6% | -2.7% | -1.4% |
| 1Y | -14.0% | -11.5% | 17.4% |
Return vs Industry: 4543 underperformed the JP Medical Equipment industry which returned -11.5% over the past year.
Return vs Market: 4543 underperformed the JP Market which returned 17.4% over the past year.
Price Volatility
| 4543 volatility | |
|---|---|
| 4543 Average Weekly Movement | 4.4% |
| Medical Equipment Industry Average Movement | 3.6% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.7% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4543 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4543's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1921 | n/a | Hikaru Samejima | www.terumo.com |
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. It operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular stent grafts, and others.
Terumo Corporation Fundamentals Summary
| 4543 fundamental statistics | |
|---|---|
| Market cap | JP¥3.68t |
| Earnings (TTM) | JP¥124.93b |
| Revenue (TTM) | JP¥1.04t |
Is 4543 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4543 income statement (TTM) | |
|---|---|
| Revenue | JP¥1.04t |
| Cost of Revenue | JP¥469.38b |
| Gross Profit | JP¥568.57b |
| Other Expenses | JP¥443.64b |
| Earnings | JP¥124.93b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Nov 12, 2025
| Earnings per share (EPS) | 84.70 |
| Gross Margin | 54.78% |
| Net Profit Margin | 12.04% |
| Debt/Equity Ratio | 12.4% |
How did 4543 perform over the long term?
See historical performance and comparisonDividends
Does 4543 pay a reliable dividends?
See 4543 dividend history and benchmarks| Terumo dividend dates | |
|---|---|
| Ex Dividend Date | Sep 29 2025 |
| Dividend Pay Date | Dec 03 2025 |
| Days until Ex dividend | 18 days |
| Days until Dividend pay date | 47 days |
Does 4543 pay a reliable dividends?
See 4543 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/16 00:07 |
| End of Day Share Price | 2025/10/16 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Terumo Corporation is covered by 30 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Steven Liu | Aletheia Analyst Network Limited |
| Masahiro Nakanomyo | Barclays |
| Ritsuo Watanabe | BofA Global Research |